Net Cash Provided by (Used in) Financing Activities in USD of CAPRICOR THERAPEUTICS, INC. from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
CAPRICOR THERAPEUTICS, INC. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2010 to Q1 2025.
  • CAPRICOR THERAPEUTICS, INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $50.4K, a 97.8% decline year-over-year.
  • CAPRICOR THERAPEUTICS, INC. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $153M, a 497% increase from 2023.
  • CAPRICOR THERAPEUTICS, INC. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $25.6M, a 425% increase from 2022.
  • CAPRICOR THERAPEUTICS, INC. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $4.87M, a 75.9% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

CAPRICOR THERAPEUTICS, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $50.4K -$2.24M -97.8% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q1 2024 $2.29M -$1.6M -41.2% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q1 2023 $3.9M +$3.87M +14082% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q1 2022 $27.5K -$12.6M -99.8% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q1 2021 $12.6M +$8.03M +177% 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022
Q1 2020 $4.55M +$3.12M +217% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021
Q1 2019 $1.43M -$1.08M -43% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020
Q1 2018 $2.51M +$2.51M 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019
Q1 2017 $0 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018
Q1 2013 $383K +$383K 01 Jan 2013 31 Mar 2013 10-Q 21 Jun 2013
Q1 2012 $0 -$6.21K 01 Jan 2012 31 Mar 2012 10-Q 21 Jun 2013
Q1 2011 $6.21K* 01 Jan 2011 31 Mar 2011 10-Q/A 15 May 2012

CAPRICOR THERAPEUTICS, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $153M +$127M +497% 01 Jan 2024 31 Dec 2024 10-K 26 Mar 2025
2023 $25.6M +$20.7M +425% 01 Jan 2023 31 Dec 2023 10-K 26 Mar 2025
2022 $4.87M -$15.4M -75.9% 01 Jan 2022 31 Dec 2022 10-K 11 Mar 2024
2021 $20.2M -$13.2M -39.4% 01 Jan 2021 31 Dec 2021 10-K 17 Mar 2023
2020 $33.4M +$24.2M +264% 01 Jan 2020 31 Dec 2020 10-K 11 Mar 2022
2019 $9.18M +$2.32M +33.9% 01 Jan 2019 31 Dec 2019 10-K 15 Mar 2021
2018 $6.85M -$4.73M -40.8% 01 Jan 2018 31 Dec 2018 10-K 27 Mar 2020
2017 $11.6M -$7.05M -37.8% 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019
2016 $18.6M 01 Jan 2016 31 Dec 2016 10-K 22 Mar 2018
2012 $1.19M -$1.12M -48.4% 01 Jan 2012 31 Dec 2012 10-K 21 Jun 2013
2011 $2.31M -$2.21M -48.9% 01 Jan 2011 31 Dec 2011 10-K 21 Jun 2013
2010 $4.52M 01 Jan 2010 31 Dec 2010 10-K 02 Apr 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.